Biosyent Stock Today
| RX Stock | CAD 11.55 0.10 0.86% |
Performance5 of 100
| Odds Of DistressLess than 1
|
Biosyent is selling for under 11.55 as of the 27th of December 2024; that is 0.86% down since the beginning of the trading day. The stock's lowest day price was 11.55. Biosyent has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 28th of September 2024 and ending today, the 27th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. The company has 11.37 M outstanding shares of which 357 shares are at this time shorted by private and institutional investors with about 0.01 trading days to cover. More on Biosyent
Moving together with Biosyent Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Biosyent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biosyent's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biosyent or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Robert March | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | ||||
Biosyent's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Biosyent's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsBiosyent can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biosyent's financial leverage. It provides some insight into what part of Biosyent's total assets is financed by creditors.
| |||||
Biosyent (RX) is traded on TSX Venture Exchange in Canada and employs 5 people. Biosyent is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 131.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biosyent's market, we take the total number of its shares issued and multiply it by Biosyent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biosyent conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.37 M outstanding shares of which 357 shares are at this time shorted by private and institutional investors with about 0.01 trading days to cover.
Biosyent currently holds about 22.46 M in cash with 5.83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Check Biosyent Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Biosyent is C$131.32 Million. Biosyent retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Biosyent Ownership Details
Biosyent Risk Profiles
Although Biosyent's alpha and beta are two of the key measurements used to evaluate Biosyent's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.43 | |||
| Semi Deviation | 1.5 | |||
| Standard Deviation | 2.0 | |||
| Variance | 4.01 |
Biosyent Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biosyent without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.